TAFAZZIN and Barth syndrome: In sum, this study shows the ability of TAZ gene replacement to dramatically improve mitochondrial structure, mtDNA copy numbers, and mitochondrial function in human BTHS cells representing TAZ mutations of varied severity and supports further translation of AAV-mediated gene therapy for BTHS into the clinical realm.